Table 5 Exploratory measures of physical and mental health.
B. longum 1714 | Placebo | P-value | |||
|---|---|---|---|---|---|
N | Mean ± SD | N | Mean ± SD | ||
Energy/vitality (SF-36) | |||||
Baseline | 44 | 68.0 ± 15.0 | 45 | 69.0 ± 14.0 | |
Week 4 | 42 | 72.0 ± 13.0 | 43 | 69.0 ± 16.0 | 0.08 |
Week 8 | 42 | 75.0 ± 12.0 | 41 | 70.0 ± 16.0 | 0.03 |
Social functioning (SF-36) | |||||
Baseline | 44 | 85.0 ± 12.0 | 45 | 83.0 ± 12.0 | |
Week 4 | 42 | 87.0 ± 10.0 | 43 | 81.0 ± 17.0 | 0.07 |
Week 8 | 42 | 89.0 ± 9.9 | 41 | 82.0 ± 16.0 | 0.04 |
Physical functioning (SF-36) | |||||
Baseline | 44 | 97.0 ± 5.5 | 45 | 98.0 ± 3.5 | |
Week 4 | 42 | 98.0 ± 5.4 | 43 | 98.0 ± 3.9 | 0.63 |
Week 8 | 42 | 98.0 ± 5.3 | 41 | 97.0 ± 10.0 | 0.16 |
Role limited through physical health (SF-36) | |||||
Baseline | 44 | 97.0 ± 8.0 | 45 | 97.0 ± 11.0 | |
Week 4 | 42 | 93.0 ± 20.0 | 43 | 89.0 ± 22.0 | 0.28 |
Week 8 | 42 | 94.0 ± 17.0 | 41 | 95.0 ± 19.0 | 0.78 |
Role limited through emotional problems (SF-36) | |||||
Baseline | 44 | 95.0 ± 16.0 | 45 | 97.0 ± 12.0 | |
Week 4 | 42 | 96.0 ± 11.0 | 43 | 88.0 ± 25.0 | 0.04 |
Week 8 | 42 | 93.0 ± 20.0 | 41 | 90.0 ± 25.0 | 0.32 |
Emotional wellbeing (SF-36) | |||||
Baseline | 44 | 82.0 ± 9.5 | 45 | 81.0 ± 10.0 | |
Week 4 | 42 | 83.0 ± 10.0 | 43 | 82.0 ± 9.7 | 0.48 |
Week 8 | 42 | 83.0 ± 11.0 | 41 | 82.0 ± 11.0 | 0.51 |
Pain (SF-36) | |||||
Baseline | 44 | 93.0 ± 11.0 | 45 | 90.0 ± 12.0 | |
Week 4 | 42 | 95.0 ± 8.2 | 43 | 90.0 ± 15.0 | 0.28 |
Week 8 | 42 | 91.0 ± 17.0 | 41 | 90.0 ± 17.0 | 0.93 |
General health (SF-36) | |||||
Baseline | 44 | 75.0 ± 9.0 | 45 | 75.0 ± 8.3 | |
Week 4 | 42 | 78.0 ± 9.5 | 43 | 75.0 ± 9.4 | 0.07 |
Week 8 | 42 | 77.0 ± 8.9 | 41 | 76.0 ± 10.0 | 0.36 |
